Lv1
36 积分 2023-07-14 加入
PCC0208057 as a small molecule inhibitor of TRPC6 in the treatment of prostate cancer
2个月前
已完结
TRPC6 inhibition by Z3571: A structure-based strategy to ameliorate glomerular and tubular dysfunction in chronic kidney disease
2个月前
已完结
NO- and Heme-Independent sGC Activators, Runcaciguat and Nurandociguat, as New Treatment Options for CKD: From Bench to Bedside
3个月前
已关闭
First-in-class versus best-in-class: an update for new market dynamics
3个月前
已完结
First-in-Human Study of SK-08, a Novel Soluble Guanylyl Cyclase Activator: Safety, Pharmacokinetics, Pharmacodynamics, and Therapeutic Potential for CKD
4个月前
已关闭
Accelerated Discovery of Macrocyclic CDK2 Inhibitor QR-6401 by Generative Models and Structure-Based Drug Design
4个月前
已完结
Discovery and preclinical evaluations of TQB3616, a novel CDK4-biased inhibitor
4个月前
已完结
Discovery of Atirmociclib (PF-07220060): A Potent and Selective CDK4 Inhibitor
5个月前
已完结
Identification of Novel Mitochondrial Pyruvate Carrier Inhibitors by Homology Modeling and Pharmacophore-Based Virtual Screening
7个月前
已完结
Rational Design and Identification of ISM7594 as a Tissue-Agnostic FGFR2/3 Inhibitor
9个月前
已完结
皖公网安备34019202002308
